Incyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.About INCY
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.
CEOWilliam J. Meury
CEOWilliam J. Meury
Employees2,617
Employees2,617
HeadquartersWilmington, Delaware
HeadquartersWilmington, Delaware
Founded1991
Founded1991
Employees2,617
Employees2,617
INCY Key Statistics
Market cap19.91B
Market cap19.91B
Price-Earnings ratio16.57
Price-Earnings ratio16.57
Dividend yield—
Dividend yield—
Average volume1.84M
Average volume1.84M
High today$101.49
High today$101.49
Low today$97.94
Low today$97.94
Open price$98.25
Open price$98.25
Volume2.15M
Volume2.15M
52 Week high$109.28
52 Week high$109.28
52 Week low$53.56
52 Week low$53.56
Stock Snapshot
As of today, Incyte(INCY) shares are valued at $100.98. The company's market cap stands at 19.91B, with a P/E ratio of 16.57.
On 2026-01-03, Incyte(INCY) stock moved within a range of $97.94 to $101.49. With shares now at $100.98, the stock is trading +3.1% above its intraday low and -0.5% below the session's peak.
Trading volume for Incyte(INCY) stock has reached 2.15M, versus its average volume of 1.84M.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $109.28 and a low of $53.56.
Over the past 52 weeks, Incyte(INCY) stock has traded between a high of $109.28 and a low of $53.56.
Analyst ratings
46%
of 28 ratingsBuy
42.9%
Hold
46.4%
Sell
10.7%
People also own
Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.